Impact of Pre-transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission ☆

Mantle cell lymphoma is a rare subtype of non-Hodgkin’s lymphoma with poor prognosis and continue to be challenging to treat. The choice of first line induction regimen remains a topic of debate due paucity of clinical trials. We retrospectively evaluated 66 patients diagnosed with mantle cell lymph...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Omar Albanyan, Samer Alkassis, Seongho Kim, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Dipenkumar Modi, Joseph P. Uberti, Abhinav Deol
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wolters Kluwer Medknow Publications 2023-04-01
Sarja:	Hematology/Oncology and Stem Cell Therapy
Aiheet:	autologous stem cell transplant (asct) mantle cell lymphoma (mcl) peripheral blood stem cell transplant (pbsct)
Linkit:	https://journals.lww.com/10.1016/j.hemonc.2021.07.005
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!